Chapter 13 - Diseases of the musculoskeletal system and connective tissue (M00-M99)»Spondylopathies (M45-M49)»Ankylosing spondylitis (M45)
M45
Ankylosing spondylitis
Sub-codes (10)
- M45.0 Ankylosing spondylitis of multiple sites in spine
- M45.1 Ankylosing spondylitis of occipito-atlanto-axial region
- M45.2 Ankylosing spondylitis of cervical region
- M45.3 Ankylosing spondylitis of cervicothoracic region
- M45.4 Ankylosing spondylitis of thoracic region
- M45.5 Ankylosing spondylitis of thoracolumbar region
- M45.6 Ankylosing spondylitis lumbar region
- M45.7 Ankylosing spondylitis of lumbosacral region
- M45.8 Ankylosing spondylitis sacral and sacrococcygeal region
- M45.9 Ankylosing spondylitis of unspecified sites in spine
Related indications (MeSH) (2)
Spondylitis, Ankylosing94 drugs (57 approved, 37 experimental)
A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.
Spondylosis22 drugs (18 approved, 4 experimental)
A degenerative spinal disease that can involve any part of the VERTEBRA, the INTERVERTEBRAL DISK, and the surrounding soft tissue.